US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

The purpose of this study it to evaluate the efficacy and safety of the 20 mL BLVR System in patients with advanced upper lobe predominant emphysema.

Phase 2

Aeris Therapeutics